Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...

Background A 61-year-old man with a history of recurrent prostate cancer presented with obstructive urinary symptoms. He had been diagnosed with locally invasive adenocarcinoma of the prostate 10 ...

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

Lymphangiogenesis, detected by antibodies specific for lymphatic endothelial cells, has been associated with regional lymph node metastases and poor prognosis in carcinomas of head and neck, breast ...

Please provide your email address to receive an email when new articles are posted on . A 71-year-old Spanish man, who initially presented in 2003 with urinary hesitancy and frequency, was found to ...

A phase III trial of docetaxel versus docetaxel and radium-223 (Ra-223) in patients with metastatic castration-resistant prostate cancer (mCRPC): DORA. Keynote 057: Phase II trial of Pembrolizumab ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer care. From minimally invasive surgical advances to emerging drug combinations ...

More than 95% of prostate cancers are adenocarcinomas. If you have prostate cancer, it’s almost certainly this type. There are several other forms of prostate cancer that are extremely rare. The ...

Prostate adenocarcinoma represents the most common form of prostate cancer, affecting nearly all cases diagnosed in men. This specific type develops in the gland cells that produce prostate fluid, ...

Identification of Patient-Reported Outcome Phenotypes Among Oncology Patients With Palliative Care Needs Therefore, examining patterns of treatment refusal can highlight subgroups of patients who may ...

We have systematically analyzed the proliferative properties of the clonogenic cells of the R3327 transplantable rat prostate adenocarcinoma (colony forming units, prostatic adenocarcinoma, CFU-PA).

A 61-year-old man with a history of recurrent prostate cancer presented with obstructive urinary symptoms. At the age of 51 years, a routine physical examination discovered an incidentally elevated ...